Doximity, Inc. (DOCS)
Doximity, Inc. (DOCS) is a Healthcare stock tracked by StreetAlpha. DOCS reports earnings on Thu, Nov 5, 2026. Analyst consensus is Hold, based on the latest ratings from 6 firms (1 buy, 5 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in DOCS, 100% of them bullish and 0% bearish. In the past 30 days there were 2 dark pool prints.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 29 | Evercore ISI Group | Target lowered | Hold | — |
| Sep 8 | Freedom Capital Markets | Downgrade | Hold | — |
| Aug 21 | Barclays | Target raised | Hold | — |
| Aug 13 | Truist Securities | Target lowered | Hold | — |
| Aug 7 | JP Morgan | Maintained | Hold | — |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether DOCS is in one of them and how their past DOCS trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered DOCS in an article yet. Here's the latest on the wider market.
DOCS Congress Trades
All congress trades →| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Donald J TrumpExecutive branch | Sell | $15K – $50K | May 18, 2026 | Jul 1, 2026 | 44 d |
| Donald J TrumpExecutive branch | Sell | $1K – $15K | May 18, 2026 | Jul 1, 2026 | 44 d |
| Arjun ModyExecutive branch | Sell | $1K – $15K | Jan 30, 2026 | Apr 10, 2026 | 70 d |
| Jonathan JacksonD · IL | Sell | $15K – $50K | Nov 6, 2025 | Dec 8, 2025 | 32 d |
| Jonathan JacksonD · IL | Buy | $15K – $50K | Aug 25, 2025 | Sep 24, 2025 | 30 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

